Your account is not claimed yet. You can sign up with ORCID to claim your account.

Ashish Kumar Vyas (Ashish K Vyas, A K Vyas, Ashish Vyas)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 16

Top Venues

Hepatology communications

Alimentary pharmacology & therapeutics

Liver international : official journal of the International Association for the Study of the Liver

Scandinavian journal of immunology

All India Institute of Medical Sciences Bhopal

This page only lists publications with an associated author ORCID identifier.

Affiliation History

All India Institute of Medical Sciences Bhopal Sep 1o 2018

India

DST Inspire Faculty :: Microbiology

Publications

Mojahidul Islam, Karan Kumar, Jayesh Kumar Sevak, Ankur Jindal, Ashish Kumar Vyas, Gayatri Ramakrishna, Shyamasundaran Kottilil, Manoj Kumar Sharma, Shiv Kumar Sarin, Nirupama Trehanpati
Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN. Hepatology communications 7 (5) (2023)
Ashish Kumar Vyas
Overcoming the challenges of eliminating viral hepatitis in low- and middle-income countries. Liver international : official journal of the International Association for the Study of the Liver (2023)
Mojahidul Islam, Karan Kumar, Jayesh Kumar Sevak, Ankur Jindal, Ashish Kumar Vyas, Gayatri Ramakrishna, Shyamasundaran Kottilil, Manoj Kumar Sharma, Shiv Kumar Sarin, Nirupama Trehanpati
Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN. Hepatology communications 7 (5) (2023)
Mojahidul Islam, Karan Kumar, Jayesh Kumar Sevak, Ankur Jindal, Ashish Kumar Vyas, Gayatri Ramakrishna, Shyamasundaran Kottilil, Manoj Kumar Sharma, Shiv Kumar Sarin, Nirupama Trehanpati
Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN. Hepatology communications 7 (5) (2023)
Mojahidul Islam, Karan Kumar, Jayesh Kumar Sevak, Ankur Jindal, Ashish Kumar Vyas, Gayatri Ramakrishna, Shyamasundaran Kottilil, Manoj Kumar Sharma, Shiv Kumar Sarin, Nirupama Trehanpati
Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN. Hepatology communications 7 (5) (2023)
Mojahidul Islam, Karan Kumar, Jayesh Kumar Sevak, Ankur Jindal, Ashish Kumar Vyas, Gayatri Ramakrishna, Shyamasundaran Kottilil, Manoj Kumar Sharma, Shiv Kumar Sarin, Nirupama Trehanpati
Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN. Hepatology communications 7 (5) (2023)
Ashish Kumar Vyas, Ankur Jindal
Letter: sPD-1 as a predictor for HBsAg seroconversion-shed light on inactive carriers with chronic hepatsitis B. Alimentary pharmacology & therapeutics 55 (8) (2022)
Mojahidul Islam, Jayesh Kumar Sevak, Manoj Kumar Sharma, Ankur Jindal, Ashish Kumar Vyas, Meenu Bajpai, Gayatri Ramakrishna, Shiv Kumar Sarin, Nirupama Trehanpati
Immune predictors of hepatitis B surface antigen seroconversion in patients with hepatitis B reactivation. Alimentary pharmacology & therapeutics (2022)
Sumit K Rawat, Talha Saad, Ankur Jindal, Ashish Kumar Vyas
Coronavirus disease 2019 in pregnancy: Case report on maternal death in Sagar City of Central India. The journal of obstetrics and gynaecology research 47 (4) (2021)
Ankur Jindal, Ashish Kumar Vyas, Garima Dubey
Ponder of concern and long-term safety of infants from mothers with chronic hepatitis B treated with tenofovir disoproxil. Gut (2021)
Ashish Kumar Vyas
Letter: programmed death-1-a predictor for anti-viral treatment in chronic hepatitis B. Alimentary pharmacology & therapeutics 52 (4) (2020)
Ritu Khosla, Ashish Kumar Vyas, Nirupama Trehanpati
Dichotomy of Notch signalling in regulating tumour immune surveillance. Scandinavian journal of immunology 89 (3) (2019)
Ashish Kumar Vyas, Anirudh K Singh, Nitu Mishra, Aruna Kumar
Timing of hepatitis B virus DNA quantification and treatment approach during pregnancy. Acta obstetricia et gynecologica Scandinavica 99 (1) (2019)
Ashish Kumar Vyas, Anirudh K Singh, Sumit K Rawat, Dipesh Kale
'Status Matters: Relation between MHC levels and Hepatitis B persistence'. Liver international : official journal of the International Association for the Study of the Liver 39 (11) (2019)
Ashish Kumar Vyas, R Khosla, Nirupama Trehanpati
In Response to 'The role of circulating T follicular helper cells and regulatory cells in non-small cell lung cancer patients'. Scandinavian journal of immunology 86 (4) (2018)
S Sukriti, J S Maras, C Bihari, S Das, Ashish Kumar Vyas, S Sharma, S Hussain, S Shasthry, A Choudhary, M Premkumar, D Kumar, G Kumar, C Mukhopadhyay, A Kumar, Nirupama Trehanpati, P E Rautou, R Moreau, Shiv Kumar Sarin
Microvesicles in hepatic and peripheral vein can predict nonresponse to corticosteroid therapy in severe alcoholic hepatitis. Alimentary pharmacology & therapeutics 47 (8) (2018)

Ashish Kumar Vyas.css-eqlu8i{font-size:small;padding-left:4px;} (Ashish K Vyas, A K Vyas, Ashish Vyas)

Publication Activity (10 Years)

Top Topics

Top Venues

Ashish Kumar Vyas (Ashish K Vyas, A K Vyas, Ashish Vyas)